The Medical Letter on Drugs and Therapeutics
February 18, 2013
Subscribers: Log in to read full issue. Not a subscriber? Subscribe or purchase issue.
In Brief: Auvi-Q - A New Epinephrine Auto-Injector
February 18, 2013 (Issue: 1410)A new epinephrine auto-injector is available in the US (Auvi-Q – Sanofi; Allerject in Canada) for emergency treatment of anaphylaxis. The new device is about the length and width of a credit card and as thick as a smartphone. It has a retractable...more
1. ES Edwards et al. J Allergy Clin Immunol 2012;129:AB179, abstract 678.
2. Wholesale acquisition cost (WAC). Source: $ource® Monthly (Selected from FDB MedKnowledge™) February 5, 2013. Reprinted with permission by FDB, Inc. All rights reserved. ©2013. www.fdbhealth.com/policies/drug-pricing-policy. Actual retail prices may vary.
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.